These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6083414)

  • 1. Platelets and blood vessels.
    Born GV
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S706-13. PubMed ID: 6083414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of platelets in thrombosis and hemostasis.
    Packham MA
    Can J Physiol Pharmacol; 1994 Mar; 72(3):278-84. PubMed ID: 8069774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary thrombosis: pathogenesis and prevention.
    Born GV
    Adv Exp Med Biol; 1990; 281():355-9. PubMed ID: 2102621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine diphosphate as a mediator of platelet aggregation in vivo.
    Born GV
    Adv Exp Med Biol; 1985; 192():399-409. PubMed ID: 3914836
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid.
    Lefort J; Vargaftig BB
    Br J Pharmacol; 1978 May; 63(1):35-42. PubMed ID: 647162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypass. Altered shear-induced pathway.
    Tabuchi N; Huet RC; Sturk A; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):813-8. PubMed ID: 7564450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of platelet aggregation and release: their possible role in vascular injury.
    Ardlie NG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):891-905. PubMed ID: 4610504
    [No Abstract]   [Full Text] [Related]  

  • 9. Annual oration on small cells and great problems.
    Born GV
    Trans Med Soc Lond; 1982-1984; 99-100():44-52. PubMed ID: 6765412
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
    Packham MA; Mustard JF
    Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
    Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
    Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)].
    Tobelem G; Drouet L; Caen J
    Nouv Presse Med; 1980 Mar; 9(13):949-54. PubMed ID: 6987618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of platelets and blood vessels--vascular injuries induced by platelet activation in vivo.
    Yamazaki H; Fujimoto T; Suzuki H; Akamatsu N; Katagiri Y; Yamaguchi A; Tanoue K
    Jpn Circ J; 1992 Feb; 56(2):178-86. PubMed ID: 1548839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation of platelets in damaged vessels.
    Born GV; Görög P; Kratzer MA
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):241-50. PubMed ID: 6117888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
    Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
    Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
    Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
    Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The P2 receptors in platelet function.
    Hechler B; Cattaneo M; Gachet C
    Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
    Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
    Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of measurement of platelet reactivity to ADP in patients with coronary artery disease: an historical account.
    Tantry US; Mahla E; Gesheff MG; Gurbel PA
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1547-56. PubMed ID: 24147519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.